# List of papers on computational immunology and others
>this repository is inspired by [Kevin Kaichuang Yang](https://github.com/yangkky) and [Sean Peldom Zhang](https://github.com/Peldom). Their works [Machine-learning-for-proteins](https://github.com/yangkky/Machine-learning-for-proteins) and [papers_for_protein_design_using_DL](https://github.com/Peldom/papers_for_protein_design_using_DL) are so unparalleled that I can't help but to follow their steps. I establish the repository mainly for systematically organizing these papers read by iqb members, so that anyone interested in cancer immunology and machine learning for protein can learn about the latest achievement in the field thorough the papers. I will try my best to keep this repository updated. <br>
If you have any questions, please contact me at [tintinjiangiwls@gmail.com] or Kevin Chun CHAN [kevin@skblnw.com].<br>

>Any contributions and suggestions are welcomed!ðŸŽ‰ðŸŽ‰ðŸ’—ðŸ’—<br>

>**Note**: The papers are sorted by their themes and the time they are published.

<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #193441, #FCFFF5);">

## Content
- [Reviews and Surveys](#reviews-and-surveys)
    - [R-Cancer Immunology](#r-cancer-immunology)
    - [R-Model and Technology](#r-model-and-technology)
        - [R-Protein Language Model](#r-protein-language-model)
        - [R-Drug Design](#r-drug-design)
- [Letters](#letters)
- [Cancer Immunology](#cancer-immunology)
- [Model and Technology](#model-and-technology)
    - [protein language model](#model-and-technology)
- [Drug Design](#drug-design)
- [Covid-19](#covid-19)
- [Other](#other)

<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #FCFFF5, #193441);">

## Reviews-and-surveys

### R Cancer Immunology
- [T-cell antigen receptor genes and T-cell recognition](https://www.nature.com/articles/334395a0)<br>
    -nature<br>
    -Published: 01 August 1988<br>
    -DOI: https://doi.org/10.1038/334395a0<br>
    `T-cell antigen receptor` `T-cell recognition`

- [Immunophilin-sensitive protein phosphatase action in cell signaling pathways](https://www.sciencedirect.com/science/article/abs/pii/0092867492901589)<br>
    -Cell<br>
    -Published: 07 August 1992<br>
    -DOI: https://doi.org/10.1016/0092-8674(92)90158-9<br>
    `Immunophilin-sensitive protein phosphatase` `cell signaling pathways`

- [Receptor Proximity, Not Intermolecular Orientation, Is Critical for Triggering T-cell Activation](https://www.jbc.org/article/S0021-9258(19)31608-4/fulltext)<br>
    -Journal of Biological Chemistry<br>
    -Published: 30 May 2001<br>
    -DOI: https://doi.org/10.1074/jbc.270.37.21689<br>
    `T-cell receptor` `T-cell activation`

- [How T cells 'see' antigen](https://www.nature.com/articles/ni1173)<br>
    -nature immunology<br>
    -Published: 18 February 2005<br>
    -DOI: https://doi.org/10.1038/ni1173<br>
    `T cells` `antigen`

- [How TCRs Bind MHCs, Peptides, and Coreceptors](https://www.annualreviews.org/doi/abs/10.1146/annurev.immunol.23.021704.115658?casa_token=UX5NPq3yCSwAAAAA%3AC0QwSB3EHkzUhuPtEk6hcsG7q0eKQEwITESyblVpueLN_zSgnHzXtgW0IRYCZwY2ecsziKAWaxWX)<br>
    -Annual Review of Immunology<br>
    -Published: 16 January 2006<br>
    -DOI: https://doi.org/10.1146/annurev.immunol.23.021704.115658<br>
    `TCRs` `MHCs` `peptides` `coreceptors`

- [The HLA genomic loci map: expression, interaction, diversity and disease](https://www.nature.com/articles/jhg20085)<br>
    -Journal of Human Genetics<br>
    -Published: 09 January 2009<br>
    -DOI: https://doi.org/10.1038/jhg.2008.5<br>
    `HLA` `genomic loci` `expression` `interaction` `diversity` `disease`

- [Neoantigens in cancer immunotherapy](https://www.science.org/doi/abs/10.1126/science.aaa4971?casa_token=Rcn7b-lb7AQAAAAA:01QOb2lx4S6xYLYakDOwtKZeRwNGQRYajAiEMqjequ91XsNIbeg8EwTiTsGM5RLu_cx1FCcT2sLCcw)<br>
    -Science<br>
    -Published: 03 April 2015<br>
    -DOI: https://doi.org/10.1126/science.aaa4971<br>
    `neoantigens` `cancer immunotherapy`

- [Elements of cancer immunity and the cancerâ€“immune set point](https://www.nature.com/articles/nature21349)<br>
    -nature<br>
    -Published:18 January 2017<br>
    -DOI: https://doi.org/10.1038/nature21349<br>
    `cancer immunity` `cancerâ€“immune set point`

[Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients](https://www.frontiersin.org/articles/10.3389/fimmu.2017.01702/full)<br>
    -frontiersin.org<br>
    -Published: 30 December 2017<br>
    -DOI: https://doi.org/10.3389/fimmu.2017.01702<br>
    `neoantigens` `immune responses` `cancer patients`

- [Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy](https://www.science.org/doi/full/10.1126/science.aao4572?casa_token=qovDDlHWSQgAAAAA%3Ab1Hb0d0x2vt60ziNY4YJfXILDOObVZpLDoCe43zT53m2vEBHZ_ziH8SEWwF-AornNZciGTD927W9KA)<br>
    -Science<br>
    -Published: 07 December 2018<br>
    -DOI: https://doi.org/10.1126/science.aao4572<br>
    `HLA class I genotype` `cancer response` `checkpoint blockade immunotherapy`

- [TCR Signaling: Mechanisms of Initiation and Propagation](https://www.cell.com/trends/biochemical-sciences/fulltext/S0968-0004(17)30221-9)<br>
    -Trends in Biochemical Sciences<br>
    -Published: 18 December 2017<br>
    -DOI: https://doi.org/10.1016/j.tibs.2017.03.008<br>
    `TCR` `signaling` `initiation` `propagation`

- [Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions](https://www.frontiersin.org/articles/10.3389/fphar.2018.00185/full)<br>
    -frontiersin.org<br>
    -Published: 05 March 2018<br>
    -DOI: https://doi.org/10.3389/fphar.2018.00185<br>
    `Immunotherapy` `Radiotherapy` `Cancer Treatment`

- [The hallmarks of successful anticancer immunotherapy](https://www.science.org/doi/full/10.1126/scitranslmed.aat7807?casa_token=bK0S0QybxEoAAAAA%3A4c87KS5_FqPcV6jrS6Ydd0VFbSt4BgRj0OXuizYYuoRoaJDwoYdOvYHb77Juy_UiI6HfYrmjELabsw)<br>
    -Science Translational Medicine<br>
    -Published: 19 September 2018<br>
    -DOI: https://doi.org/10.1126/scitranslmed.aat7807<br>
    `anticancer immunotherapy` `hallmarks`

- [Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic](https://www.sciencedirect.com/science/article/pii/S0923753419309974)<br>
    -Annals of Oncology <br>
    -Published: January 2019<br>
    -DOI: https://doi.org/10.1093/annonc/mdy495<br>
    `Tumor mutation burden` `Immunotherapy` `Biomarker` `Oncology clinic`

- [The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy](https://www.nature.com/articles/s41568-019-0116-x)<br>
    -nature reviews cancer<br>
    -Published: 12 February 2019<br>
    -DOI: https://doi.org/10.1038/s41568-019-0116-x<br>
    `biomarkers` `checkpoint inhibitor immunotherapy`

- [Structure Based Prediction of Neoantigen Immunogenicity](https://www.frontiersin.org/articles/10.3389/fimmu.2019.02047/full)<br>
    -frontiersin.org<br>
    -Published: 28 August 2019<br>
    -DOI: https://doi.org/10.3389/fimmu.2019.02047<br>
    `neoantigen` `immunogenicity`

- [Tumour-intrinsic resistance to immune checkpoint blockade](https://www.nature.com/articles/s41577-019-0218-4)<br>
    -nature review immunology<br>
    -Published: 30 September 2019<br>
    -DOI: https://doi.org/10.1038/s41577-019-0218-4<br>
    `immune checkpoint blockade` `tumour-intrinsic resistance`

- [T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy](https://www.frontiersin.org/articles/10.3389/fimmu.2022.833017/full)<br>
    -frontiersin.org<br>
    -Published: 10 February 2022<br>
    -DOI: https://doi.org/10.3389/fimmu.2022.833017<br>
    `T cell` `neoantigen` `immunotherapy`

### R Model and Technology
#### R Protein Language Model
- [Controllable protein design with language models](https://www.nature.com/articles/s42256-022-00499-z)<br>
    -Nature Machine Learning<br>
    -Published: 22 June 2022<br>
    -DOI: https://doi.org/10.1038/s42256-022-00499-z<br>
    `protein language model` `protein design` `deep learning`

- [Linguistically inspired roadmap for building biologically reliable protein language models](https://www.nature.com/articles/s42256-023-00637-1)<br>
    -Nature Machine Learning<br>
    -Published: 06 April 2023<br>
    -DOI: https://doi.org/10.1038/s42256-023-00637-1<br>
    `protein language model` `protein design` `deep learning`

- [On scientific understanding with artificial intelligence](https://www.nature.com/articles/s42254-022-00518-3)<br>
    -nature reviews physics <br>
    -Published: 11 October 2022<br>
    -DOI: https://doi.org/10.1038/s42254-022-00518-3<br>
    `scientific understanding` `artificial intelligence`

#### R Drug Design
- [Deep Generative Molecular Design Reshapes Drug Discovery](https://www.cell.com/cell-reports-medicine/pdf/S2666-3791(22)00349-4.pdf)<br>
    -Cell Reports Medicine<br>
    -Published: 20 December 2022<br>
    -DOI: https://doi.org/10.1016/j.xcrm.2022.100794<br>
    `generative model` `drug design` `deep learning`


<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #193441, #FCFFF5);">

## Letters

- [Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer](https://www.nature.com/articles/nature23003)<br>
    -nature<br>
    -Published: 05 July 2017<br>
    -DOI: https://doi.org/10.1038/nature23003<br>
    `RNA mutanome vaccines` `poly-specific therapeutic immunity` `cancer`

<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #FCFFF5, #193442);">

## Cancer Immunology
- [HLA supertypes and supermotifs: a functional perspective on HLA polymorphism](https://www.sciencedirect.com/science/article/abs/pii/S0952791598801246)<br>
    -Current Opinion in Immunology<br>
    -Published: August 1998<br>
    -DOI: https://doi.org/10.1016/S0952-7915(98)80124-6<br>
    `HLA` `supertypes` `supermotifs` `HLA polymorphism`

- [Thermodynamics of T cell receptor binding to peptide-MHC: Evidence for a general mechanism of molecular scanning](https://www.pnas.org/doi/abs/10.1073/pnas.96.20.11446)<br>
    -PNAS<br>
    -Published: 28 September 1999<br>
    -DOI: https://doi.org/10.1073/pnas.96.20.11446<br>
    `T cell receptor` `peptide-MHC` `molecular scanning`

- [Distinct Molecular Mechanisms Account for the Specificity of Two Different T-Cell Receptors](https://pubs.acs.org/doi/abs/10.1021/bi026864+?casa_token=OWz2bpRMRKwAAAAA:nXnkLNSfGksVsMCXkytukGuvB0bF1ptncgCwB4Z8RyYNu_yq-7CAafXXLpjn9y21LNHdwbjsSzSlqg)<br>
    -Biochemistry<br>
    -Published: 1 April 2003<br>
    -DOI: https://doi.org/10.1021/bi026864+<br>
    `T cell` `TCR` `specificity` `molecular mechanism`

- [Large Scale Characterization of the LC13 TCR and HLA-B8 Structural Landscape in Reaction to 172 Altered Peptide Ligands: A Molecular Dynamics Simulation Study](https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1003748)<br>
    -PLOS Computational Biology<br>
    -Published: 07 April 2014<br>
    -DOI: https://doi.org/10.1371/journal.pcbi.1003748<br>
    `LC13 TCR` `HLA-B8` `altered peptide ligands` `molecular dynamics simulation`

- [Examining Variable Domain Orientations in Antigen Receptors Gives Insight into TCR-Like Antibody Design](https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1003852)<br>
    -PLOS Computational Biology<br>
    -Published: 18 September 2014<br>
    -DOI: https://doi.org/10.1371/journal.pcbi.1003852<br>
    `T cell` `TCR` `antibody design` `variable domain orientations`

- [Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens](https://www.nature.com/articles/nature13988)<br>
    -nature<br>
    -Published: 26 November 2014<br>
    -DOI: https://doi.org/10.1038/nature13988<br>
    `checkpoint blockade` `cancer immunotherapy` `tumour-specific mutant antigens`

- [A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells](https://www.science.org/doi/abs/10.1126/science.aaa3828)<br>
    -Science<br>
    -Published: 2 April 2015<br>
    -DOI: https://doi.org/10.1126/science.aaa3828<br>
    `dendritic cell vaccine` `melanoma` `neoantigen-specific T cells`

- [How structural adaptability exists alongside HLA-A2 bias in the human Î±Î² TCR repertoire](https://www.pnas.org/doi/abs/10.1073/pnas.1522069113)<br>
    -PNAS<br>
    -Published: 16 February 2016<br>
    -DOI: https://doi.org/10.1073/pnas.1522069113<br>
    `HLA-A2 bias` `human Î±Î² TCR repertoire`

- [T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable](https://www.pnas.org/doi/abs/10.1073/pnas.1718659115)<br>
    -PNAS<br>
    -Published: 07 February 2018<br>
    -DOI: https://doi.org/10.1073/pnas.1718659115<br>
    `T cell receptors` `HIV KK10 epitope` `differential immunologic control`

- [Improving T Cell Receptor On-Target Specificity via Structure-Guided Design](https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(18)30594-X)<br>
    -Molecular Therapy<br>
    -Published: 04 April 2018<br>
    -DOI: https://doi.org/10.1016/j.ymthe.2018.03.018<br>
    `T cell receptor` `on-target specificity` `structure-guided design`

- [Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial](https://www.nature.com/articles/s41586-018-0792-9)<br>
    -nature<br>
    -Published: 29 December 2018<br>
    -DOI: https://doi.org/10.1038/s41586-018-0792-9<br>
    `neoantigen vaccine` `intratumoral T cell responses` `glioblastoma`

- [Neoantigen-directed immune escape in lung cancer evolution](https://www.nature.com/articles/s41586-019-1032-7)<br>
    -nature<br>
    -Published: 20 March 2019<br>
    -DOI: https://doi.org/10.1038/s41586-019-1032-7<br>
    `neoantigen` `immune escape` `lung cancer`

- [Quantitative Prediction of the Landscape of T Cell Epitope Immunogenicity in Sequence Space](https://www.frontiersin.org/articles/10.3389/fimmu.2019.00827/full)<br>
    -frontiersin.org<br>
    -Published: 16 April 2019<br>
    -DOI: https://doi.org/10.3389/fimmu.2019.00827<br>
    `T cell epitope` `immunogenicity` `sequence space`

- [A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen](https://www.cell.com/cell/pdf/S0092-8674(19)30505-7.pdf)<br>
    -Cell<br>
    -Published: 30 May 2019<br>
    -DOI: https://doi.org/10.1016/j.cell.2019.02.007<br>
    `BCR` `T cell` `autoantigen` `Type 1 Diabetes`

- [Exploration of HIV-1 fusion peptideâ€“antibody VRC34.01 binding reveals fundamental neutralization sites](https://pubs.rsc.org/en/content/articlehtml/2019/cp/c9cp02909e?casa_token=gJS1Tj2xf-cAAAAA:dY5_PA4288jR8Uzd7mu_5haAurnpNY4DD2h0Q0hY74u-tGkg5CwdGTkG6t3ZpeFUbm3jPoYoE02M)<br>
    -Physical Chemistry Chemical Physics<br>
    -Published: 08 August 2019<br>
    -DOI: https://doi.org/10.1039/C9CP02909E<br>
    `HIV-1` `fusion peptide` `antibody` `neutralization sites`

- [MHC-II neoantigens shape tumour immunity and response to immunotherapy](https://www.nature.com/articles/s41586-019-1671-8)<br>
    -nature<br>
    -Published: 23 October 2019<br>
    -DOI: https://doi.org/10.1038/s41586-019-1671-8<br>
    `MHC-II neoantigens` `tumour immunity` `immunotherapy`

- [A molecular basis for the T cell response in HLA-DQ2.2 mediated celiac disease](https://www.pnas.org/doi/abs/10.1073/pnas.1914308117)<br>
    -PNAS<br>
    -Published: 23 January 2020<br>
    -DOI: https://doi.org/10.1073/pnas.1914308117<br>
    `Celiac Disease` `HLA-DQ2.2` `TCR` `Immunogenicity` `Gliadin Peptides`

- [Commensal bacteria stimulate antitumor responses via T cell cross-reactivity](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205429/)<br>
    -JCI Insight<br>
    -Published: 23 April 2020<br>
    -DOI: https://doi.org/10.1172/jci.insight.135597<br>
    `Commensal bacteria` `antitumor responses` `T cell cross-reactivity`

- [High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D](https://www.pnas.org/doi/abs/10.1073/pnas.1921964117)<br>
    -PNAS<br>
    -Published: 27 May 2020<br>
    -DOI: https://doi.org/10.1073/pnas.1921964117<br>
    `TCR` `T cell therapy` `mutant KRAS-G12D` `high-affinity oligoclonal`

- [Impact of Cysteine Residues on MHC Binding Predictions and Recognition by Tumor-Reactive T Cells](https://journals.aai.org/jimmunol/article/205/2/539/110175?casa_token=6XLQ4nJDd5MAAAAA:EpLWn0bx5osgeP1LOpCEQMVE34JJkOuOUUo_yZejq2pE7deTNxUjZlRjElPAVajGlV1Brg)<br>
    -the Journal of Immunology<br>
    -Published: 15 July 2020<br>
    -DOI: https://doi.org/10.4049/jimmunol.1901173<br>
    `MHC` `T cell` `cysteine residues` `binding predictions`

- [Canonical T cell receptor docking on peptideâ€“MHC is essential for T cell signaling](https://www.science.org/doi/full/10.1126/science.abe9124?casa_token=6E3TFOrwX9cAAAAA%3AG6c7m5C92BCPW0YTwEPXN3_YDcWtc3Jq0pxhu3TTEDHquzXGfmau37E5iZrmfK3rfY-DS-wzB-I_)<br>
    -Science<br>
    -Published: 04 June 2020<br>
    -DOI: https://doi.org/10.1126/science.abe9124<br>
    `T cell receptor` `peptideâ€“MHC` `T cell signaling`

- [Predicting Cross-Reactivity and Antigen Specificity of T Cell Receptors](https://www.frontiersin.org/articles/10.3389/fimmu.2020.565096/full)<br>
    -frontiersin.org<br>
    -Published: 22 October 2020<br>
    -DOI: https://doi.org/10.3389/fimmu.2020.565096<br>
    `T cell receptor` `cross-reactivity` `antigen specificity`

- [Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44](https://www.nature.com/articles/s43018-020-00140-1)<br>
    -nature cancer<br>
    -Published: 16 November 2020<br>
    -DOI: https://doi.org/10.1038/s43018-020-00140-1<br>
    `mutational landscape` `immunotherapy` `non-small-cell lung cancer` `human leukocyte antigen supertype B44`

- [Identification of bacteria-derived HLA-bound peptides in melanoma](https://www.nature.com/articles/s41586-021-03368-8)<br>
    -nature<br>
    -Published: 17 March 2021<br>
    -DOI: https://doi.org/10.1038/s41586-021-03368-8<br>
    `bacteria-derived` `HLA-bound peptides` `melanoma`

- [Targeting a neoantigen derived from a common TP53 mutation](https://www.science.org/doi/full/10.1126/science.abc8697?casa_token=cmfnMEIa5RMAAAAA%3AZ2Lb-_1iUI9YIE__d9-49IJTJkIPI4RHQ5LK6UyF5tODFnrKwz_uTTu4pvbOeC7-CVt0Exgqa8PM6w)<br>
    -Science<br>
    -Published: 01 March 2021<br>
    -DOI: https://doi.org/10.1126/science.abc8697<br>
    `neoantigen` `TP53 mutation`

- [Neoantigen Controversies](https://www.annualreviews.org/doi/abs/10.1146/annurev-biodatasci-092820-112713)<br>
    -Annual Review of Biomedical Data Science<br>
    -Published: 08 July 2021<br>
    -DOI: https://doi.org/10.1146/annurev-biodatasci-092820-112713<br>
    `neoantigen` `controversies`

- [Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers](https://www.nature.com/articles/s41586-021-03752-4)<br>
    -nature<br>
    -Published: 21 July 2021<br>
    -DOI: https://doi.org/10.1038/s41586-021-03752-4<br>
    `neoantigen-specific TIL` `anti-PD-1` `lung cancers`

- [Dynamics-Based Peptideâ€“MHC Binding Optimization by a Convolutional Variational Autoencoder: A Use-Case Model for CASTELO](https://pubs.acs.org/doi/full/10.1021/acs.jctc.1c00870)<br>
    -Journal of Chemical Theory and Computation<br>
    -Published: 18 November 2021<br>
    -DOI: https://doi.org/10.1021/acs.jctc.1c00870<br>
    `MHC` `T cell` `binding predictions` `convolutional variational autoencoder`

- [Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens](https://academic.oup.com/bib/article/23/3/bbac141/6573960)<br>
    -Briefings in Bioinformatics<br>
    -Published: 25 April 2022<br>
    -DOI: https://doi.org/10.1093/bib/bbac141<br>
    `CD8+ T cell` `pathogenic epitopes` `cancer neoantigens` `computational models`

- [Specific Genetic Polymorphisms Contributing in Differential Binding of Gliadin Peptides to HLA-DQ and TCR to Elicit Immunogenicity in Celiac Disease](https://link.springer.com/article/10.1007/s10528-023-10377-x#Abs1)<br>
    -Biochemical Genetics<br>
    -Published: 27 April 2023<br>
    -DOI: https://doi.org/10.1007/s10528-023-10377-x<br>
    `Celiac Disease` `HLA-DQ` `TCR` `Immunogenicity` `Gliadin Peptides`

- [Pan-KRAS inhibitor disables oncogenic signalling and
tumour growth](https://www.nature.com/articles/s41586-023-06123-3)<br>
    -nature<br>
    -Published: 31 May 2023<br>
    -DOI: https://doi.org/10.1038/s41586-023-06123-3<br>
    `KRAS` `pan-KRAS inhibitor` `oncogenic signalling` `tumour growth`

- [A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection](https://www.nature.com/articles/s41586-023-06331-x)<br>
    -nature<br>
    -Published: 19 July 2023<br>
    -DOI: https://doi.org/10.1038/s41586-023-06331-x<br>
    `HLA` `SARS-CoV-2` `asymptomatic infection`

- [A membrane-associated MHC-I inhibitory axis for cancer immune evasion](https://www.cell.com/cell/pdf/S0092-8674(23)00783-3.pdf)<br>
    -Cell<br>
    -Published: 8 August 2023<br>
    -DOI: https://doi.org/10.1016/j.cell.2023.07.026<br>
    `MHC-I` `cancer immune evasion` `membrane-associated` `inhibitory axis`

- [Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS](https://www.science.org/doi/full/10.1126/science.adg9652?casa_token=YZtzYJhYntkAAAAA%3A7WsUudgDlDa7X4etI_e0axz0QsYmWa7wjhMeFC_aYvrMhx0O7_gMCDCLxzsYXIYm6RfN-hmPzYiA)<br>
    -Science<br>
    -Published: 17 August 2023<br>
    -DOI: https://doi.org/10.1126/science.adg9652<br>
    `KRAS` `chemical remodeling` `chaperone`

- [Quantitative approaches for decoding the specificity of the human T cell repertoire](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539903/)<br>
    -frontiers in immunology<br>
    -Published: 7 September 2023<br>
    -DOI: https://doi.org/10.3389%2Ffimmu.2023.1228873<br>
    `T cell` `TCR` `specificity` `quantitative approaches`

- [Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses](https://www.nature.com/articles/s41587-023-01957-8)<br>
    -Nature Biotechnology<br>
    -Published: 25 September 2023<br>
    -DOI: https://doi.org/10.1038/s41587-023-01957-8<br>
    `tumor-associated bacteria` `liposomal antibiotic` `neoantigens` `anti-tumor immune responses`

- [The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity](https://www.nature.com/articles/s41586-023-06575-7)<br>
    -Nature<br>
    -Published: 04 October 2023<br>
    -DOI: https://doi.org/10.1038/s41586-023-06575-7<br>
    `PTPN2` `PTPN1` `ABBV-CLS-484` `anti-tumour immunity`

- [Cancer- and infection-induced T cell exhaustion are distinct](https://www.nature.com/articles/s41590-023-01624-9)<br>
    -nature immunology<br>
    -Published: 14 November 2023<br>
    -DOI: https://doi.org/10.1038/s41590-023-01624-9<br>
    `T cell` `exhaustion` `cancer` `infection`

- [Targeting of intracellular oncoproteins with peptide-centric CARs](https://www.nature.com/articles/s41586-023-06706-0)<br>
    -nature<br>
    -Published: 08 November 2023<br>
    -DOI: https://doi.org/10.3389%2F<br>
    `peptide-centric chimeric antigen receptors `

- [Nanomedicine-based co-delivery of a calcium channel inhibitor and a small molecule tar- geting CD47 for lung cancer immunotherapy](https://www.nature.com/articles/s41467-023-42972-2)<br>
    -nature communications<br>
    -Published: 11 November 2023<br>
    -DOI: https://doi.org/10.1038/s41467-023-42972-2<br>
    `calcium channel inhibitor` `CD47` `lung cancer immunotherapy` `nanomedicine`

<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #193441, #FCFFF5);">

## Model and Technology
### protein language model
- [DeepAntigen: a novel method for neoantigen prioritization via 3D genome and deep sparse learning](https://academic.oup.com/bioinformatics/article/36/19/4894/5864021)<br>
    -Bioinformatics<br>
    -Published: 11 September 2020<br>
    -DOI: https://doi.org/10.1093/bioinformatics/btaa686<br>
    `neoantigen` `3D genome` `deep sparse learning`

- [Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens](https://academic.oup.com/bib/article/23/3/bbac141/6573960)<br>
    -Briefings in Bioinformatics<br>
    -Published: 25 April 2022<br>
    -DOI: https://doi.org/10.1093/bib/bbac141<br>
    `CD8+ T cell` `pathogenic epitopes` `cancer neoantigens` `computational models`

- [ProtGPT2 is a deep unsupervised language model for protein design](https://www.nature.com/articles/s41467-022-32007-7)<br>
    -nature communications<br>
    -Published: 27 July 2022<br>
    -DOI: https://doi.org/10.1038/s41467-022-32007-7<br>
    `protein language model` `protein design` `deep learning`

- [Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences](https://www.nature.com/articles/s41551-022-00991-2)<br>
    -Nature Biomedical Engineering<br>
    -Published: 12 January 2023<br>
    -DOI: https://doi.org/10.1038/s41551-022-00991-2<br>
    `antimicrobial peptides` `machine-learning pipeline` `peptide sequences`

- [Efficient evolution of human antibodies from general protein language models](https://www.nature.com/articles/s41587-023-01763-2)<br>
    -Nature Biotechnology<br>
    -Published: 24 April 2023<br>
    -DOI: https://doi.org/10.1038/s41587-023-01763-2<br>
    `protein language model` `antibody design` `deep learning`

- [Neural relational inference to learn long-range allosteric interactions in proteins from molecular dynamics simulations](https://www.nature.com/articles/s41467-022-29331-3)<br>
    -nature communications<br>
    -Published: 29 March 2022<br>
    -DOI: https://doi.org/10.1038/s41467-022-29331-3<br>
    `protein` `allosteric interactions` `molecular dynamics simulations` `neural network`

- [Chemical complexity challenge: Is multi-instance machine learning a solution?](https://wires.onlinelibrary.wiley.com/doi/full/10.1002/wcms.1698)<br>
    -WIREs Computational Molecular Science<br>
    -Published: 27 November 2023<br>
    -DOI: https://doi.org/10.1002/wcms.1698<br>
    `multi-instance machine learning` `chemical complexity`

- [TCR-H: Machine Learning Prediction of T-cell Receptor Epitope Binding on Unseen Datasets](https://www.biorxiv.org/content/10.1101/2023.11.28.569077v1)<br>
    -bioRxiv<br>
    -Published: 28 November 2023<br>
    -DOI: https://doi.org/10.1101/2023.11.28.569077<br>
    `TCR` `machine learning` `negative data bias`
 

<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #FCFFF5, #193441);">

## Drug Design

- [m<sup>1</sup>A in CAG repeat RNA binds to TDP-43 and induces neurodegeneration](https://www.nature.com/articles/s41586-023-06701-5)<br>
    -nature<br>
    -Published: 08 November 2023<br>
    -DOI: https://doi.org/10.1038/s41586-023-06701-5<br>
    `m1A` `CAG repeat RNA` `TDP-43` `neurodegeneration`
  
<hr style="height:2px;border-width:0;background-image: linear-gradient(to right, #FCFFF5, #193441);">

## Covid-19
- [Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor](https://www.nature.com/articles/s41586-020-2180-5)<br>
    -Nature<br>
    -Published: 30 March 2020<br>
    -DOI: http://dx.doi.org/10.1038/s41586-020-2180-5"<br>
    `SARS-COV-2` `ACE2` `spike protein` `receptor-binding domain` `crystal structure`

## Other
- [Genetic risk converges on regulatory networks mediating early type 2 diabetes](https://www.nature.com/articles/s41586-023-06693-2)<br>
    -nature<br>
    -Published: 04 December 2023<br>
    -DOI: https://doi.org/10.1038/s41586-023-06693-2<br>
    `type 2 diabetes` `genetic risk` `regulatory networks`
